Rock Compounds logo
AX-2026-2278-2EKYv1
Epitalon · Lot EPI10-0819-001 · Rock Compounds
CRYPTOGRAPHICALLY SEALED
SHA-384: c28210170e6fedd7
Scan to verify
PRODUCT ATTRIBUTION
Rock Compounds logo
Rock Compounds
Rock Compounds, LLC
Brand identity verified
Submitted by: Rock Compounds, LLC

Originated by Rock Compounds, LLC, which attests it authorized this test as the brand of record.

Axiom confirmed this brand is a registered Axiom account. This does not confirm the product's origin, chain of custody, or that the brand authorized this specific test.

Open / Print PDF
SAMPLE & VIAL VALIDATION
Validated vial
Vial as received & analyzed
BrandRock Compounds
ProductEpitalon
Lot / BatchEPI10-0819-001
Label Claim10 mg
Matrixlyophilized powder
Sample Count1
Vial Size3mL
Cap ColorBlue
Crimp ColorSilver / Aluminum
Contents ColorWhite
Seal IntactYes
Conditionsealed, intact

Test Results

IdentityReferencewithin ±1 Da of 390.349 DaResult390.349 Da (error 0 Da)PASS
PurityReferenceat least 98% (Axiom Analytics internal specification ≥95%)Result99.75%PASS
Net Peptide ContentReferencewithin ±10% of the 10 mg label claimResult9.88 mg (-1.2%)PASS
Sterility · Rapid PCRReferenceRapid PCR screenResultNo Growth
EndotoxinReference≤ 0.5 EU/mg (USP <85>)Result0.25 EU/mgPASS
Heavy MetalsReferenceUSP <232>/<233> limitsResultAll below limitsPASS
StabilityReferencepH within 4.50 - 7.00 and degradation below 5%ResultpH 5.75, 2.5% degradation at 24 hPASS
Fentanyl ScreenReferenceno fentanyl or analog at or above 1 ng/mgResultnone detectedPASS

Rapid PCR reports a microbial DNA target screen. It is not a USP <71> batch sterility determination.

Heavy Metals

ElementSpecificationResultVerdict
Lead (Pb)≤ 500 ppbNot DetectedPASS
Arsenic (As)≤ 1500 ppbNot DetectedPASS
Cadmium (Cd)≤ 200 ppbNot DetectedPASS
Mercury (Hg)≤ 300 ppbNot DetectedPASS
Cobalt (Co)≤ 500 ppbNot DetectedPASS
Vanadium (V)≤ 1000 ppbNot DetectedPASS
Nickel (Ni)≤ 2000 ppbNot DetectedPASS
REVIEW & DIGITAL SIGNATURES
Analyst
Alana Reeves
ed25519:d03598623321037a85e48191...
Technical Reviewer
Michael Niles
ed25519:46c4ca7760acf98fee924f5b...
Laboratory Director
Daniel Brennan
ed25519:cfd336ce2389eae79f1c08ed...
Released Aug 26, 2026, 13:00 UTC
This report is immutable. Any alteration breaks the cryptographic seal. Verify independently at /verify/AX-2026-2278-2EKY
REPORTING SCOPE

Results relate only to the item or portion tested. Unless sampling was performed or witnessed by Axiom Analytics, the laboratory does not attest that the submitted sample represents the wider lot or batch. A PASS designation means only that the reported result met the specification shown. It does not establish safety, efficacy, regulatory approval, legality, or suitability for human or animal use.

RESEARCH USE ONLY

All analytical testing, validation reports, and interactive Certificates of Analysis (COAs) provided by Axiom Analytics are intended strictly for Research Use Only (RUO) in in-vitro or laboratory animal model environments. Axiom Analytics does not analyze, validate, evaluate, or make any representations regarding the safety, efficacy, toxicity, or legality of any tested substance for human or animal consumption, veterinary use, clinical diagnostics, food additives, cosmetics, or household applications.

ANALYSIS & ACCREDITATION

Physical instrument analysis is performed at Axiom Analytics' discretion (based on method, capacity, and order volume), either in Axiom's own laboratory under its documented quality system or by an independent partner laboratory engaged under confidentiality. Where analysis is subcontracted, the method is performed within the partner laboratory's published ISO/IEC 17025 scope of accreditation for that method, not merely at a laboratory holding ISO/IEC 17025 accreditation. Axiom Analytics does not itself currently hold ISO/IEC 17025 accreditation. The method-validation status of each reported result is identified beside that result. Partner laboratory identities are not disclosed: samples are analyzed under double-blind conditions, identified only by an internal lot ID.

LIMITATION OF LIABILITY

To the maximum extent permitted by applicable law, the cumulative liability of Axiom Analytics, its officers, employees, and third-party laboratory partners to the client or any third party for any claims, losses, damages, or liabilities of any kind (including but not limited to direct, indirect, special, incidental, punitive, or consequential damages) shall be strictly limited to, and shall not exceed, the exact dollar amount paid by the client to Axiom Analytics for the specific individual analytical test run from which the liability arose.